Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Alopecia areata may be caused by the immune system attacking hair follicles.

Alefacept does not effectively treat severe alopecia areata.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

Finasteride increases CD8+ T cells in BPH tissues.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Regulatory T cells enhance bone formation by influencing cell mechanics.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Enhancing immune response can improve cancer treatment effectiveness.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Farudodstat may effectively treat alopecia areata without harming hair follicles.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

CS12192 effectively treats alopecia areata with better safety than current options.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.